PL2035457T3 - Nośnik szczepionki - Google Patents
Nośnik szczepionkiInfo
- Publication number
- PL2035457T3 PL2035457T3 PL07718492T PL07718492T PL2035457T3 PL 2035457 T3 PL2035457 T3 PL 2035457T3 PL 07718492 T PL07718492 T PL 07718492T PL 07718492 T PL07718492 T PL 07718492T PL 2035457 T3 PL2035457 T3 PL 2035457T3
- Authority
- PL
- Poland
- Prior art keywords
- vaccine carrier
- vaccine
- carrier
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32711—Rhinovirus
- C12N2770/32734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0099406A AT503690A1 (de) | 2006-06-09 | 2006-06-09 | Hypoallergene moleküle |
PCT/AT2007/000281 WO2007140505A2 (en) | 2006-06-09 | 2007-06-11 | Vaccine carrier |
EP07718492.7A EP2035457B1 (en) | 2006-06-09 | 2007-06-11 | Vaccine carrier |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2035457T3 true PL2035457T3 (pl) | 2015-10-30 |
Family
ID=38650124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07718492T PL2035457T3 (pl) | 2006-06-09 | 2007-06-11 | Nośnik szczepionki |
Country Status (14)
Country | Link |
---|---|
US (2) | US9296828B2 (pl) |
EP (2) | EP2035457B1 (pl) |
JP (3) | JP5399895B2 (pl) |
CN (3) | CN101466738A (pl) |
AT (1) | AT503690A1 (pl) |
AU (1) | AU2007257308B2 (pl) |
BR (1) | BR122019004393B1 (pl) |
CA (1) | CA2657971C (pl) |
DK (2) | DK2924047T3 (pl) |
ES (2) | ES2698525T3 (pl) |
PL (1) | PL2035457T3 (pl) |
PT (1) | PT2035457E (pl) |
RU (1) | RU2486206C2 (pl) |
WO (1) | WO2007140505A2 (pl) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2190473T3 (da) | 2007-08-15 | 2013-03-25 | Circassia Ltd | Peptid med reduceret dimerdannelse |
PT2153841E (pt) * | 2008-08-15 | 2012-03-21 | Circassia Ltd | Vacina compreendendo péptidos amb a 1 para utilização no tratamento de alergia a ambrósia |
EP2384336B1 (en) * | 2008-12-30 | 2014-03-05 | Chua, Kaw Yan | A variant of mite allergen and uses thereof |
CO6260019A1 (es) | 2009-01-30 | 2011-03-22 | Fundacion Universidad Del Norte | Metodo y composicion inmunoquimica para la deteccion de alergenos de acaros usando anticuerpos policlonales igy |
US8753644B2 (en) * | 2009-02-05 | 2014-06-17 | Circassia Limited | Grass peptides for vaccine |
AU2013202362B2 (en) * | 2009-02-05 | 2015-09-17 | Circassia Limited | Grass Peptides for Vaccine |
EP2316481A1 (en) * | 2009-10-30 | 2011-05-04 | Biomay Ag | Pharmaceutical composition for the treatment and prevention of a rhinovirus infection |
US9308251B2 (en) * | 2011-06-09 | 2016-04-12 | Biomay Ag | Peptide carrier fusion proteins as allergy vaccines |
AU2012277491B2 (en) * | 2011-06-27 | 2017-03-23 | Anergis S.A. | Contiguous overlapping peptides for treatment of ragweed pollen allergy |
EP2543725A1 (en) * | 2011-07-08 | 2013-01-09 | Biomay Ag | Polysaccharide lyases |
JO3820B1 (ar) | 2012-05-03 | 2021-01-31 | Regeneron Pharma | أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها |
GB201209868D0 (en) * | 2012-06-01 | 2012-07-18 | Circassia Ltd | Alternaria peptides |
EP2727934B1 (en) | 2012-09-20 | 2016-06-15 | Universidad de Cartagena | Fusion proteins with representation of different allergens: vaccine proposal for mite allergies |
JP2014231500A (ja) * | 2013-05-29 | 2014-12-11 | 元晴 植原 | シラカンバ花粉症の免疫療法に用いるペプチド混合物 |
EP3564671B1 (en) | 2013-08-23 | 2021-09-29 | Regeneron Pharmaceuticals, Inc. | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit) |
US11013781B2 (en) | 2015-07-01 | 2021-05-25 | Alk-Abelló As | Peptide combinations and uses thereof for treating grass allergy |
US11352417B2 (en) | 2016-12-22 | 2022-06-07 | Regeneron Pharmaceuticals, Inc. | Method of treating an allergy with allergen-specific monoclonal antibodies |
US11408895B1 (en) | 2018-04-09 | 2022-08-09 | Hob Biotech Group Corp., Ltd. | Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay |
EP3569612A1 (en) * | 2018-05-18 | 2019-11-20 | Biomay Ag | Treatment and prevention of house dust mite allergies |
RU2761431C9 (ru) | 2020-10-26 | 2022-04-18 | Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) | Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
GB8821077D0 (en) | 1988-09-08 | 1988-10-05 | Wellcome Found | Peptides |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US6019972A (en) * | 1989-11-03 | 2000-02-01 | Immulogic Pharmaceutical Corporation | Peptides of human T cell reactive feline protein (TRFP) |
GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
NZ244782A (en) * | 1991-10-16 | 1996-12-20 | Immulogic Pharma Corp | Isolated peptides having t-cell stimulating activity, pharmaceutical composition |
IL105153A (en) * | 1992-03-25 | 1999-12-22 | Immulogic Pharma Corp | Therapeutic compositions comprising peptides derived from human t cell reactive feline protein |
US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
AT401937B (de) * | 1993-04-01 | 1996-12-27 | Biomay Prod & Handel | Rekombinantes lieschgras pollen allergen phl p ii |
DE69333979T2 (de) * | 1993-04-14 | 2006-12-21 | Heska Corp.(n.d.Ges, d.Staates Delaware), Loveland | T-zell epitope der hauptallergene von dermatophagoides (hausstaubmilbe) |
DK0755407T3 (da) * | 1994-04-14 | 2007-08-06 | Merck Patent Gmbh | Farmaceutisk peptidformuleringer til behandling af stövmideallergi |
SE9402089D0 (sv) * | 1994-06-14 | 1994-06-14 | Rudolf Valenta | Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments |
US6572859B1 (en) * | 1999-10-29 | 2003-06-03 | Pharmacia Diagnostics Ab | Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use |
US20030166518A1 (en) * | 2000-01-13 | 2003-09-04 | Beardslee Thomas A. | Method for allergen characterization |
DE60137230D1 (de) | 2000-07-06 | 2009-02-12 | Univ Georgetown | Stabile (fixierte) formen von viralen l1 capsidproteinen, deren fusionsproteinen, und deren verwendungen |
ES2209563B1 (es) | 2000-07-28 | 2005-10-01 | Universidad Complutense De Madrid | Produccion en la levadurapipchia pastoris y sistema de purificacion del alergeno recombinante de olea europaea ole e 1 para uso en diagnosis y tratamiento de alergias. |
NZ525820A (en) | 2000-11-16 | 2005-01-28 | Alk Abello As | Mutant allergens |
EP1221317A1 (en) * | 2000-12-28 | 2002-07-10 | SHAN-Beteiligungsgesellschaft m.b.H. | Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins |
US7264810B2 (en) * | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
ATE443716T1 (de) | 2002-02-27 | 2009-10-15 | Merck Patent Gmbh | Verfahren zur herstellung von hypoallergenem birkenpollenhauptallergen rbet v 1 |
EP1534344A4 (en) | 2002-06-26 | 2008-05-28 | Advanced Bionutrition Corp | VIRUSES AND VIRUSIC PARTICLES FOR MULTIPLE ANTIGEN AND TARGET DISPLAY |
JP4953570B2 (ja) | 2002-07-05 | 2012-06-13 | フォリア バイオテック インコーポレイテッド | アジュバントウィルス粒子 |
DE60301944T2 (de) | 2003-01-21 | 2006-06-01 | Biomay Produktions- Und Handels-Aktiengesellschaft | Verfahren zur Vorbereitung von hypoallergenen Mosaikproteinen# |
GB0308988D0 (en) | 2003-04-17 | 2003-05-28 | Univ Singapore | Molecule |
ES2434720T3 (es) * | 2003-06-04 | 2013-12-17 | Merck Patent Gmbh | Derivados de LOL P 5 con alergenicidad reducida y reactividad frente a células T mantenida |
US20050053615A1 (en) * | 2003-07-16 | 2005-03-10 | Best Elaine A. | Variants of mite group 1 allergens for the treatment of house dust mite allergy |
DE10351471A1 (de) * | 2003-11-04 | 2005-06-09 | Ursula Prof. Dr. Wiedermann-Schmidt | Polyvalente Allergievakzine |
MXPA06006221A (es) * | 2003-12-01 | 2008-02-13 | Dow Global Technologies Inc | Produccion de particula tipo virus icosaedrico recombinante en organismos del genero pseudomonas. |
CN1926238A (zh) * | 2004-02-27 | 2007-03-07 | 陶氏化学公司 | 植物细胞中的高效肽生产 |
ITRM20040103A1 (it) * | 2004-02-27 | 2004-05-27 | Consiglio Nazionale Ricerche | Proteine di fusione comprendenti allergeni della famiglia delle ns-ltps, loro usi e composizioni farmaceutiche che le comprendono. |
US20060088549A1 (en) * | 2004-07-08 | 2006-04-27 | Arnold Gail F | Chimeric virus vaccine |
DE102004035337A1 (de) | 2004-07-21 | 2006-03-16 | Merck Patent Gmbh | Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität |
MX2007003171A (es) * | 2004-09-21 | 2007-05-23 | Cytos Biotechnology Ag | Particulas tipo virus que comprenden una proteina de fusion de la proteina de cubierta de ap205 y un polipeptido antigenico. |
AT501101B1 (de) | 2004-12-02 | 2008-01-15 | Biomay Ag | Protein-allergen-derivat |
US7767212B2 (en) * | 2005-03-18 | 2010-08-03 | Cytos Biotechnology Ag | CAT allergen conjugates and uses thereof |
AU2006291835B2 (en) * | 2005-09-15 | 2012-04-05 | Alk-Abello A/S | A method for quantification of allergens |
-
2006
- 2006-06-09 AT AT0099406A patent/AT503690A1/de not_active Application Discontinuation
-
2007
- 2007-06-11 ES ES15161237T patent/ES2698525T3/es active Active
- 2007-06-11 PL PL07718492T patent/PL2035457T3/pl unknown
- 2007-06-11 PT PT77184927T patent/PT2035457E/pt unknown
- 2007-06-11 BR BR122019004393-0A patent/BR122019004393B1/pt active IP Right Grant
- 2007-06-11 JP JP2009513514A patent/JP5399895B2/ja active Active
- 2007-06-11 CN CNA200780021374XA patent/CN101466738A/zh active Pending
- 2007-06-11 CN CN2013102084632A patent/CN103319601A/zh active Pending
- 2007-06-11 RU RU2008152045/10A patent/RU2486206C2/ru active
- 2007-06-11 EP EP07718492.7A patent/EP2035457B1/en active Active
- 2007-06-11 CA CA2657971A patent/CA2657971C/en active Active
- 2007-06-11 US US12/304,267 patent/US9296828B2/en active Active
- 2007-06-11 EP EP15161237.1A patent/EP2924047B1/en active Active
- 2007-06-11 WO PCT/AT2007/000281 patent/WO2007140505A2/en active Application Filing
- 2007-06-11 AU AU2007257308A patent/AU2007257308B2/en active Active
- 2007-06-11 ES ES07718492.7T patent/ES2541311T3/es active Active
- 2007-06-11 CN CN201310209988.8A patent/CN103319602B/zh active Active
- 2007-06-11 DK DK15161237.1T patent/DK2924047T3/en active
- 2007-06-11 DK DK07718492.7T patent/DK2035457T3/en active
-
2013
- 2013-10-24 JP JP2013221629A patent/JP2014087341A/ja active Pending
- 2013-10-24 JP JP2013221630A patent/JP2014064573A/ja active Pending
-
2015
- 2015-12-17 US US14/972,685 patent/US20160257722A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090324501A1 (en) | 2009-12-31 |
CN103319602A (zh) | 2013-09-25 |
BR122019004393B1 (pt) | 2023-10-17 |
AU2007257308B2 (en) | 2013-06-06 |
CA2657971C (en) | 2018-01-23 |
PT2035457E (pt) | 2015-07-28 |
JP5399895B2 (ja) | 2014-01-29 |
US20160257722A1 (en) | 2016-09-08 |
WO2007140505A3 (en) | 2008-03-20 |
DK2924047T3 (en) | 2018-12-03 |
JP2014087341A (ja) | 2014-05-15 |
ES2698525T3 (es) | 2019-02-05 |
CN101466738A (zh) | 2009-06-24 |
WO2007140505A2 (en) | 2007-12-13 |
AU2007257308A1 (en) | 2007-12-13 |
US9296828B2 (en) | 2016-03-29 |
CA2657971A1 (en) | 2007-12-13 |
CN103319602B (zh) | 2016-09-07 |
RU2486206C2 (ru) | 2013-06-27 |
EP2924047A1 (en) | 2015-09-30 |
EP2035457A2 (en) | 2009-03-18 |
EP2035457B1 (en) | 2015-04-01 |
RU2008152045A (ru) | 2010-07-20 |
JP2014064573A (ja) | 2014-04-17 |
JP2009539354A (ja) | 2009-11-19 |
BRPI0712421A2 (pt) | 2012-06-19 |
EP2924047B1 (en) | 2018-08-22 |
DK2035457T3 (en) | 2015-06-15 |
ES2541311T3 (es) | 2015-07-17 |
CN103319601A (zh) | 2013-09-25 |
AT503690A1 (de) | 2007-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2035457T3 (pl) | Nośnik szczepionki | |
GB0607088D0 (en) | Vaccine | |
EP2056861A4 (en) | IMPF-IMMUNOTHERAPY | |
GB0616306D0 (en) | Vaccines | |
GB0700135D0 (en) | Vaccine | |
HK1129836A1 (zh) | 疫苗 | |
GB0614460D0 (en) | Vaccines | |
ZA200901592B (en) | Vaccine | |
EP2018095A4 (en) | INSTRUMENT SUPPORT | |
GB0724772D0 (en) | Carrier | |
GB0702229D0 (en) | Carrier | |
GB0625593D0 (en) | Vaccine | |
GB0622348D0 (en) | Retaining means | |
GB0617450D0 (en) | Liverstock carriers | |
GB0709373D0 (en) | BCG-based anti-atheroma vaccine | |
TWI346426B (en) | Carrier | |
GB0606256D0 (en) | Anti-atheroma vaccine | |
GB0608962D0 (en) | Vaccine | |
GB0620815D0 (en) | Vaccine | |
GB0619820D0 (en) | Vaccine | |
GB0619822D0 (en) | Vaccine | |
GB0619826D0 (en) | Vaccine | |
GB0619824D0 (en) | Vaccine | |
GB0607087D0 (en) | Vaccine | |
GB0620816D0 (en) | vaccine |